Tourette Syndrome

Definition and Diagnostic Criteria

• Tourette syndrome (TS) is a common neurodevelopmental disorder characterized by the presence of both multiple motor tics and one or more vocal (phonic) tics.
• Under current diagnostic criteria, the tics must have been present at some time during the illness, wax and wane in frequency, and persist for more than 1 year since the first tic onset.
• The onset of the disorder must occur before the age of 18 years, with most children developing tics between 5 and 7 years of age.
• The disturbance must not be attributable to the physiological effects of a substance (e.g., cocaine) or another general medical condition (e.g., Huntington disease, postviral encephalitis).

Core Clinical Features

• Motor Tics: These are sudden, rapid, recurrent, nonrhythmic stereotyped movements.
  • Simple motor tics involve one or a few muscle groups (e.g., eye blinking, neck jerking, shoulder shrugging).
  • Complex motor tics are relatively coordinated movements that may seem purposeful (e.g., tapping the foot, brushing hair, imitating others [echopraxia], or obscene gestures [copropraxia]).
• Vocal (Sonic) Tics: These encompass repeated words, phrases, or sounds.
  • Simple vocal tics include throat clearing, sniffing, and grunting.
  • Complex vocal tics include recognizable words, uttering obscenities (coprolalia), repeating one's own words (palilalia), or repeating the last heard phrase (echolalia).
• Premonitory Urge and Suppressibility: A hallmark of TS is a premonitory urge or feeling of tension preceding the movement, which is temporarily relieved after the tic is performed. Patients have the ability to voluntarily suppress the tics for brief periods.
• Temporal Course: Tic severity typically peaks between the ages of 10 and 12 years and markedly attenuates in roughly 65% of individuals by 18 to 20 years of age. Tics frequently exacerbate during periods of stress, excitement, or exhaustion.
• Malignant Tourette Syndrome: A severe variant characterized by highly disabling, potentially life-threatening symptoms, including extreme rage attacks, severe self-injurious behavior (e.g., cervical myelopathy from neck thrusting, severe biting of lips), and depression with suicidal ideation.

Etiology and Pathophysiology

• TS is a highly heritable polygenic condition, with monozygotic twin concordance rates approximating 80%.
• The disorder has a strong male predominance, with a gender ratio ranging from 2:1 to 4:1.
• Pathophysiologically, it results from dysfunctional corticostriatal-thalamocortical motor pathways within the basal ganglia, striatum, and frontal lobes.
• It involves abnormalities in central neurotransmitter systems, specifically dopamine, serotonin, and norepinephrine, which is corroborated by the clinical responsiveness of tics to dopamine-blocking and dopamine-depleting medications.

The "Tourette Syndrome Triad" and Comorbidities

• The clinical presentation is best recognized through the "Tourette syndrome triad," highlighting the frequent clustering of tics, Attention-Deficit/Hyperactivity Disorder (ADHD), and Obsessive-Compulsive Disorder (OCD).
• ADHD: The most common comorbidity, occurring in 60% to 80% of clinically referred children with TS.
• OCD: Occurs in 20% to 60% of TS patients. The intrusive thoughts and stereotyped compulsions of OCD share neurobiology with tics and strongly cluster in affected families.
• Additional associations include learning disabilities, depression, anxiety, and oppositional behaviors.

Differential Diagnosis and Evaluation

• The diagnosis of TS is strictly clinical; there are no confirmatory laboratory or neuroimaging tests, and brain MRI or EEG is typically normal unless atypical neurologic signs are present.

Management Principles

• Education and Reassurance: For the majority of children with mild to moderate tics, medical treatment is unnecessary. Supportive counseling and psychoeducation for the family and school are the preferred first-line interventions.
• Behavioral Therapy: Habit-Reversal Training (HRT) and Comprehensive Behavioral Intervention for Tics (CBIT) are strongly supported first-line treatments. They involve premonitory urge awareness training and teaching a competing motor response.
• Pharmacotherapy: Reserved for tics causing significant functional disability, social isolation, pain, or self-injury.

• Management of Comorbidities: Treating comorbid ADHD (using stimulants or atomoxetine) and OCD (using Cognitive Behavioral Therapy and SSRIs) is crucial, as these often cause more functional impairment than the tics themselves. Stimulants can be used carefully, though they must be monitored for potential tic exacerbation.